Irepertoire Inc.
Huntsville, AL
- UEI
- GT35KNG2JGF4
- CAGE
- 5EE39
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Huntsville, AL 35806, USA
- Website
- irepertoire.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $7,158 |
| FY2023 | $59,880 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Creative Enzymes | Shirley, NY | 541713 Research and Development in Nanotechnology |
| Genscript Probio USA Inc. | Pennington, NJ | 325414 Biological Product (except Diagnostic) Manufacturing |
| Creative Biogene Inc. | Shirley, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Mirimus, Inc. | NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Ampseq LLC | Gaithersburg, MD | 541380 Testing Laboratories and Services |
About the company
Irepertoire Inc. is a small disadvantaged business specializing in advanced molecular biology and immunological research services, primarily focusing on immune system analysis and sequencing technologies. Registered in SAM.gov since April 2009, the company operates as a for-profit corporate entity with extensive experience in providing sophisticated scientific research services to federal agencies. While limited public information is available about the company's full background, its federal contract history demonstrates a strong expertise in cutting-edge immunological research techniques, particularly in T-cell receptor sequencing and related molecular analysis.
The company has consistently secured federal contracts from multiple civilian agencies, with a primary concentration on health-related research institutions. Irepertoire Inc. has been awarded numerous purchase orders and definitive contracts from agencies such as the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute (NCI), Veterans Health Administration (VHA), Centers for Disease Control and Prevention (CDC), and the National Eye Institute. Its core services include T-cell receptor sequencing, RNA extraction, PCR amplification, deep immune repertoire sequencing, and advanced laboratory testing services. The contracts, ranging in value from approximately $4,680 to $45,800, typically involve specialized research supporting immunological, infectious disease, and cancer research efforts. All of these contracts have been awarded without specific set-aside designations, indicating the company's competitive capabilities in securing federal research support across various scientific domains.
SBA capabilities narrative
iRepertoire, Inc., supplies products and services for the molecular analysis of the immune system using next-generation sequencing (NGS). These services include cell sorting, nucleic acid extraction, immune repertoire amplification, and NGS on Illumina systems. We also recently introduced single cell services for the pairing of receptor V(D)J rearrangements for human TCR alpha, beta, and immunoglobulin heavy and light chains. These technologies can be applied to a wide array of immune-based areas including autoimmunity, cancer research, and infectious disease. Our single cell technology is particularly applicable to immune-based drug development and can detect paired V(D)J rearrangements for rare populations of cells.
Quick answers
Is Irepertoire Inc. registered in SAM.gov?
Yes. Irepertoire Inc.'s SAM.gov registration is active through May 15, 2027.
How much has Irepertoire Inc. received in federal contracts?
Federal contracts obligated $67,038 to Irepertoire Inc. in fiscal years 2023 through 2027.
What is Irepertoire Inc.'s most recent federal award?
Irepertoire Inc.'s most recent federal contract award is RNA sequencing services for mouse t cell receptor (75N93024P01168), from National Institute of Allergy and Infectious Diseases (NIH), on September 17, 2024.
On GovTribe
See Irepertoire Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors